PHASE-I INTRAVENOUS (IV) TOXICITY STUDY OF N-METHYLFORMAMIDE (NMF) (NSC-3051) IN CDF1 MICE AND BEAGLE DOGS

被引:0
|
作者
NEWMAN, KN
MEEKS, RG
FRICK, S
机构
[1] SO RES INST,BIRMINGHAM,AL 35225
[2] BATTELLE MEM INST,TPO,VIENNA,VA 22180
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1982年 / 23卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:202 / 202
页数:1
相关论文
共 4 条
  • [1] PHASE-I STUDY OF N-METHYLFORMAMIDE (NMF,NSC-3051)
    VANECHO, DA
    SIGMAN, LM
    DONEHOWER, M
    ODWYER, PJ
    FORTNER, C
    WHITACRE, MY
    AISNER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 169 - 169
  • [2] PHASE-I TRIAL OF N-METHYLFORMAMIDE (NMF, NSC-3051)
    ODWYER, PJ
    DONEHOWER, M
    SIGMAN, LM
    FORTNER, CL
    AISNER, J
    VANECHO, DA
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 853 - 857
  • [3] INTRAVENOUS LETHALITY AND TOXICITY STUDIES IN CDF1 MICE AND TOXICITY STUDY IN BEAGLE DOGS OF HENKEL COMPOUND (NSC-296934)
    LIAO, JT
    FRICK, S
    UNWIN, SE
    CARTER, JL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 205 - 205
  • [4] ASSESSMENT OF N-METHYLFORMAMIDE (NMF) ADMINISTERED ORALLY ON A 3 TIMES WEEKLY SCHEDULE - A PHASE-I STUDY
    ROWINSKY, EK
    GROCHOW, LB
    HANTEL, A
    ETTINGER, DS
    VITO, BL
    DONEHOWER, RC
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (04) : 317 - 325